We are dedicated to helping people suffering from neuropsychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines.
Beckley Psytech’s innovative approach to helping patients in need is focused on developing psychedelic pharmacotherapy, psychotherapy and digital therapy to improve patient outcomes
For our founders, Lady Amanda Feilding and Cosmo Feilding Mellen, psychedelic medicines have been a lifelong and intergenerational vocation.
We’re building a pipeline of differentiated compounds to evaluate the potential of psychedelics and psychedelic-assisted psychotherapy in a variety of mental health and neurological disorders.
Get in touch to learn more about our work.